Jing-Lun Yen Selected Research

2,3,7,7a- tetrahydro- 3- hydroxy- 7- methyl- 2- (prop- 1- en- 1- yl)- 5H- furo(3,4- b)pyran- 5- one

1/2018

Theissenolactone C Exhibited Ocular Protection of Endotoxin-Induced Uveitis by Attenuating Ocular Inflammatory Responses and Glial Activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jing-Lun Yen Research Topics

Disease

3	Neuroinflammatory Diseases 05/2021 - 01/2018
1	Nervous System Diseases (Neurological Disorders) 05/2021
1	Cerebral Hemorrhage 05/2021
1	Sepsis (Septicemia) 06/2019
1	Acute Lung Injury 06/2019
1	Endotoxemia 06/2019
1	Uveitis 01/2018
1	Anterior Uveitis 01/2018
1	Inflammation (Inflammations) 01/2018
1	Hyperemia 01/2018
1	Retinal Degeneration 01/2017
1	Gliosis 01/2017

Drug/Important Bio-Agent (IBA)

2	LipopolysaccharidesIBA 06/2019 - 01/2019
2	Matrix Metalloproteinases (MMPs)IBA 06/2019 - 01/2017
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2019
1	hirsutanol AIBA 06/2019
1	CytokinesIBA 06/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Neuroprotective AgentsIBA 01/2019
1	Retinaldehyde (Retinal)IBA 01/2018
1	2,3,7,7a- tetrahydro- 3- hydroxy- 7- methyl- 2- (prop- 1- en- 1- yl)- 5H- furo(3,4- b)pyran- 5- oneIBA 01/2018
1	EndotoxinsIBA 01/2018
1	iridalIBA 01/2018
1	chrysophanic acidIBA 01/2017
1	Rhodopsin (Visual Purple)IBA 01/2017
1	OpsinsIBA 01/2017

Therapy/Procedure

1	Therapeutics 05/2021